JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms
Open Access
- 15 November 2002
- journal article
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 115 (22) , 4317-4325
- https://doi.org/10.1242/jcs.00082
Abstract
Phosphorylation of the N-terminal domain of Jun by the Jun kinases (JNKs) modulates the transcriptional activity of AP-1, a dimeric transcription factor typically composed of c-Jun and c-Fos, the latter being essential for osteoclast differentiation. Using mice lacking JNK1 or JNK2, we demonstrate that JNK1, but not JNK2, is specifically activated by the osteoclast-differentiating factor RANKL. Activation of JNK1, but not JNK2, is required for efficient osteoclastogenesis from bone marrow monocytes (BMMs). JNK1 protects BMMs from RANKL-induced apoptosis during differentiation. In addition, BMMs from mice carrying a mutant of c-Jun phosphorylation sites (JunAA/JunAA), as well as cells lacking either c-Jun or JunD, which is another JNK substrate, revealed that c-Jun phosphorylation and c-Jun itself, but not JunD, are essential for efficient osteoclastogenesis. Moreover, JNK1-dependent c-Jun phosphorylation in response to RANKL is not involved in the anti-apoptotic function of JNK1. Thus, these data provide genetic evidence that JNK1 activation modulates osteoclastogenesis through both c-Jun-phosphorylation-dependent and -independent mechanisms.Keywords
This publication has 42 references indexed in Scilit:
- Differential effects of JNK1 and JNK2 on signal specific induction of apoptosisOncogene, 2002
- Joint damage and inflammation in c‐Jun N‐terminal kinase 2 knockout mice with passive murine collagen‐induced arthritisArthritis & Rheumatism, 2002
- Carbonic anhydrase II is an AP‐1 target gene in osteoclastsJournal of Cellular Physiology, 2001
- AP-1 in mouse development and tumorigenesisOncogene, 2001
- Tumor Necrosis Factor-α (TNF) Stimulates RANKL-induced Osteoclastogenesis via Coupling of TNF Type 1 Receptor and RANK Signaling PathwaysJournal of Biological Chemistry, 2001
- Tumor necrosis factor receptors types 1 and 2 differentially regulate osteoclastogenesisJournal of Biological Chemistry, 2000
- Requirement of JNK for Stress- Induced Activation of the Cytochrome c-Mediated Death PathwayScience, 2000
- Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of OsteoporosisEndocrine Reviews, 2000
- Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand FamiliesEndocrine Reviews, 1999
- TRAF2 Is Essential for JNK but Not NF-κB Activation and Regulates Lymphocyte Proliferation and SurvivalImmunity, 1997